Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia

✍ Scribed by O'Hear, Carol; Inaba, Hiroto; Pounds, Stanley; Shi, Lei; Dahl, Gary; Bowman, W. Paul; Taub, Jeffrey W.; Pui, Ching-Hon; Ribeiro, Raul C.; Coustan-Smith, Elaine; Campana, Dario; Rubnitz, Jeffrey E.

• Book ID: 121209361
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 314 KB
• Volume: 119
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.28334